Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iota carrageenan nasal spray for prevention of rhinovirus colds
ACTRN12614000026628Phase 3Completed
- Sponsor
- Julian Crane
- Start
- Apr 2014
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial in rhinoviral infection and nasopharyngitis comparing Active iota carrageenan nasal spray with Placebo saline nasal spray (2 arms). Primary endpoint: Reduction in cold symptoms. Started Apr 2014; status: completed.
02
Drugs
Iota-carrageenan
03
Conditions
rhinoviral infectionnasopharyngitis
Beyond the preview
Go deeper on ACTRN12614000026628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000026628.